01.12.2012 Views

View - ResearchSpace@Auckland - The University of Auckland

View - ResearchSpace@Auckland - The University of Auckland

View - ResearchSpace@Auckland - The University of Auckland

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ecruit blood vessels in the lung. Studies have also suggested that a normal NO reading at the<br />

beginning <strong>of</strong> exercise predicted that no exercise-induced bronchospasm occurred.<br />

Low nasal NO appears to be helpful in screening for PCD and possibly CF. It is particularly<br />

important to measure this in children with established bronchiectasis and detecting a low NO<br />

level early in assessment for recurrent respiratory illnesses would be additionally beneficial<br />

and would indicate that these diseases must be investigated and excluded. <strong>The</strong> low NO levels<br />

seen in PCD remain unexplained, while those in CF and other conditions such as sinusitis<br />

would appear to be secondary to sinus obstruction. Oral NO levels are also low in PCD, but<br />

the nasal NO measurements (using a cut point <strong>of</strong> 250ppb) have minimal overlap with normal<br />

children. Oral NO levels become low in CF with age and disease progression, probably with<br />

entrapment <strong>of</strong> NO within thick mucus and therefore likely to interact with other compounds,<br />

so the NO does not reach the air to be exhaled. NO levels are increased in acute infections in<br />

both normal subjects and those with COPD, and increase during times <strong>of</strong> higher pollution and<br />

also associated with respiratory symptoms. However 'smoking' remains a confounding factor<br />

here -<br />

again rendering the measurement <strong>of</strong> NO as useless. In interstitial lung disease, levels <strong>of</strong><br />

NO co-relate with severity, in particular that assessed by the diffusion co-efficient, but only<br />

when measured in the alveolar compartment. <strong>The</strong> measurement <strong>of</strong> NO has been undertaken in<br />

infants and here while the parameters are still being worked through, it appears that the results<br />

are already low in those with PCD and CF, and high in children with wheeze, though it is still<br />

to be clarified whether this will result in detecting asthma versus infant viral associated<br />

wheeze, and whether it matters, as it may just detect disease that will respond to steroids.<br />

<strong>The</strong> advantages <strong>of</strong> using NO measurement rather than (or in addition to) other parameters is<br />

obvious. It is much easier to perform, especially in children, than lung function testing or<br />

induced sputum for eosinophils or any <strong>of</strong> the blood measurements such as total IgE. In<br />

addition it is quicker, with immediate results, and potentially can be done away <strong>of</strong>f hospital<br />

site. While it still needs an understanding <strong>of</strong> the test and qualified personnel, it can be taught<br />

and undertaken more easily than the other investigations.<br />

So where do I see it as cunently being MOST useful:<br />

l. Nasal (and oral) measurement as a screen for PCD. If nasal levels are low - ensure<br />

investigation for PCD and CF are carried out. While we do have a newborn screening<br />

for CF here in New Zealand,87o <strong>of</strong> children are not detected.<br />

2. As confirmation <strong>of</strong> asthma in steroid natve patients - when NO levels should be high.<br />

260

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!